BACKGROUND: Reported associations of condom use and human papillomavirus (HPV) infection have been inconsistent. We investigated self-reported frequency of condom use and detection of genital HPV among men. METHODS: A cross-sectional analysis was conducted in men aged 18-70 years from Brazil, Mexico, and the United States. Men completed questionnaires on sexual history, condom use, and sociodemographic characteristics. Among 2621 men reporting recent vaginal sex, prevalence of any HPV, any oncogenic type, and nononcogenic types only was estimated by frequency of condom use ("always" or "not always"). Multivariable models were used to estimate prevalence ratios (PRs) for HPV according to frequency of condom use. RESULTS: The prevalence of any HPV was 70.5%; any oncogenic type, 34%, and nononcogenic types only, 22.2%. The adjusted PR for always vs not always using condoms was 0.87 (95% confidence interval [CI], .77-.97) for all countries combined. The association was stronger in the United States (PR, 0.70; CI, .55-.90) than in Brazil (PR, 0.84; CI, .71-1.01) or Mexico (PR, 1.05; CI, .89-1.25) (P for interaction = .025). CONCLUSIONS: HPV prevalence was high even among those who reported always using condoms, and its associations with always using condoms varied among countries.
BACKGROUND: Reported associations of condom use and human papillomavirus (HPV) infection have been inconsistent. We investigated self-reported frequency of condom use and detection of genital HPV among men. METHODS: A cross-sectional analysis was conducted in men aged 18-70 years from Brazil, Mexico, and the United States. Men completed questionnaires on sexual history, condom use, and sociodemographic characteristics. Among 2621 men reporting recent vaginal sex, prevalence of any HPV, any oncogenic type, and nononcogenic types only was estimated by frequency of condom use ("always" or "not always"). Multivariable models were used to estimate prevalence ratios (PRs) for HPV according to frequency of condom use. RESULTS: The prevalence of any HPV was 70.5%; any oncogenic type, 34%, and nononcogenic types only, 22.2%. The adjusted PR for always vs not always using condoms was 0.87 (95% confidence interval [CI], .77-.97) for all countries combined. The association was stronger in the United States (PR, 0.70; CI, .55-.90) than in Brazil (PR, 0.84; CI, .71-1.01) or Mexico (PR, 1.05; CI, .89-1.25) (P for interaction = .025). CONCLUSIONS:HPV prevalence was high even among those who reported always using condoms, and its associations with always using condoms varied among countries.
Authors: Rachel L Winer; James P Hughes; Qinghua Feng; Sandra O'Reilly; Nancy B Kiviat; King K Holmes; Laura A Koutsky Journal: N Engl J Med Date: 2006-06-22 Impact factor: 91.245
Authors: R A Crosby; W L Yarber; S A Sanders; C A Graham; K McBride; R R Milhausen; J N Arno Journal: Sex Transm Infect Date: 2006-07-26 Impact factor: 3.519
Authors: Ann N Burchell; Harriet Richardson; Salaheddin M Mahmud; Helen Trottier; Pierre P Tellier; James Hanley; François Coutlée; Eduardo L Franco Journal: Am J Epidemiol Date: 2006-01-18 Impact factor: 4.897
Authors: Richard Crosby; Ralph J Diclemente; William L Yarber; Gregory Snow; Adewale Troutman Journal: Sex Transm Dis Date: 2008-02 Impact factor: 2.830
Authors: Marcia L Shew; J Dennis Fortenberry; Wanzhu Tu; Beth E Juliar; Byron E Batteiger; Brahim Qadadri; Darron R Brown Journal: Arch Pediatr Adolesc Med Date: 2006-02
Authors: Jennifer S Smith; Stephen Moses; Michael G Hudgens; Kawango Agot; Silvia Franceschi; Ian W Maclean; J O Ndinya-Achola; Corette B Parker; Norma Pugh; Chris J L M Meijer; Peter J F Snijders; Robert C Bailey Journal: Sex Transm Dis Date: 2007-11 Impact factor: 2.830
Authors: Michael P Chen; Maurizio Macaluso; Richard Blackwell; Loren Galvao; Andrzej Kulczycki; Juan Diaz; Denise J Jamieson; Ann Duerr Journal: Sex Transm Dis Date: 2007-08 Impact factor: 2.830
Authors: T Cai; G Perletti; F Meacci; V Magri; P Verze; A Palmieri; S Mazzoli; R Santi; G Nesi; V Mirone; R Bartoletti Journal: Eur J Clin Microbiol Infect Dis Date: 2016-01-11 Impact factor: 3.267
Authors: Aaron A R Tobian; Mary K Grabowski; Godfrey Kigozi; Patti E Gravitt; Kevin P Eaton; David Serwadda; Fred Nalugoda; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: Sex Transm Infect Date: 2012-05-24 Impact factor: 3.519
Authors: Emmanuel Chandler; Lili Ding; Pamina Gorbach; Eduardo L Franco; Darron A Brown; Lea E Widdice; David I Bernstein; Jessica A Kahn Journal: J Adolesc Health Date: 2018-07 Impact factor: 5.012
Authors: Cody J Warren; Tao Xu; Kejun Guo; Laura M Griffin; Joseph A Westrich; Denis Lee; Paul F Lambert; Mario L Santiago; Dohun Pyeon Journal: J Virol Date: 2014-10-29 Impact factor: 5.103
Authors: Christine M Pierce Campbell; Hui-Yi Lin; William Fulp; Mary R Papenfuss; Jorge J Salmerón; Manuel M Quiterio; Eduardo Lazcano-Ponce; Luisa L Villa; Anna R Giuliano Journal: J Infect Dis Date: 2013-05-03 Impact factor: 5.226
Authors: Linda L Theisen; Clemens A J Erdelmeier; Gilles A Spoden; Fatima Boukhallouk; Aurélie Sausy; Luise Florin; Claude P Muller Journal: PLoS One Date: 2014-01-31 Impact factor: 3.240
Authors: Elena Lopez-Diez; Sonia Perez; Manuel Carballo; Amparo Iñarrea; Angel de la Orden; Maximo Castro; Moises Rodríguez; Sheila Almuster; Ruben Montero; Miguel Perez; Jorge Sanchez; Antonio Ojea Journal: PLoS One Date: 2017-09-12 Impact factor: 3.240